Compositions useful as inhibitors of protein kinases

Details Compositions useful as inhibitors of protein kinases Compositions useful as inhibitors of protein kinases

2004-03-25

2009-06-16

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S404000, C549S408000

Reexamination Certificate

active

07547794

ABSTRACT:
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

REFERENCES:
patent: 4065574 (1977-12-01), Moon et al.
patent: 5593989 (1997-01-01), Peglion et al.
patent: 5733920 (1998-03-01), Mansuri et al.
patent: WO 98/17662 (1998-04-01), None
patent: WO 01/53266 (2001-07-01), None
Dermer (Bio/Technology, 1994, 12:320).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
MSNBC News Services, “Mixed results on new cancer drug”, Nov. 9, 2000.
Gura (Science, v278, 1997, pp. 1041-1042).
(Gulati et al. STN Accession No. 1936:61866; Document No. 30:61866; Abstract of Current Science (1936),5,75).
Ishchenko et al. STN: Accession # Abstract of Geterotsiklicheskikh Soedinenii) (2002), 38(3), 274-280.
Lacova et al. STN Accession # Abstract of Molecules [Electronic Publication] (1998), 3(3), 120-131.
Meshcheryakova et al. STN Accession # Abstract of Khimiko-Farmatsevticheskii Zhurnal (1976), 10(3), 37-41.
Basinski et al STN Accession # Abstract of Polish Journal of Chemistry (1991), 65(9-10), 1619-32.
Ishchenko et al. STN Accession # Abstract of Khimiya Geterotsiklicheskikh Soedinenii (1995), (3), 322-4.
Grishko et al. Ukrainskii Khimicheskii Zhurnal (Russian Edition) (1985), 51(2), 211-17.
Balbi et al. STN Accession # Abstract of Farmaco, Edizione Scientifica (1982), 37(6), 387-97.
Beugelmans et al. STN Accession # Abstract of Tetrahedron Letters (1976), (25), 2145-8.
Vorozhtsov et al STN Accession # Abstract of Doklady Akademii Nauk SSSR (1965), 164(5), 1046-9.
Bell et al. STN Accession # Abstract ofAustralian Journal of Chemistry (1963), 16(4), 690-4.
Blicke et al. STN Accession # Abstract of Journal of Organic Chemistry (1960), 25, 693-8.
Beugelmans et al. STN Accession # Abstract ofTetrahedron Letters, 1976 25, 2145-8.
Aitmambetov et. al. STN Accession # Abstract of (Natural Compounds (Translation of Khimiya Prirodnykh Soedinenii) (2000), 36(1), 47-50).
Ishchenko et al. STN Abstract of Geterotsiklicheskikh Soedinenii) (2002), 38(3),274-280.
Murti et al., STN Abstract of Tetrahedron Letters (1964), (39-40), 2995-7.
Kariyone STN Abstract of Yakugaku Zasshi (1960), 80, 746-9; Yakugaku Zasshi (1960), 80, 749-52.
Spatz, STN Abstract of Journal of Organic Chemistry (1959), 24, 1381-2.
Rahatgaonkar et al. STN Abstract of Indian Journal of Heterocyclic Chemistry (1996), 5(4), 323-324.
Basinski et al. STN Abstract of Polish Journal of Chemistry (1991), 65(9-10), 1619-32.
Kostanecki et al. STN Abstract of Berichte der Deutschen Chemischen Gesellschaft (1908) 41, 783-6.
Basinski, STN Accession No. 1992:214399 Document No. 116:214399; Abstract of Polish Journal of Chemistry (1991), 65(9-10), 1619-32.
Heideman et al., “Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4,” J. Gene Medicine6: 317-327 (2004).
Tomioka et al., “Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model,”Cancer Research61: 7518-7524 (2001).
Saga et al., “Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival,”Gene Therapy8: 1450-1455 (2001).
Martin et al., “Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist,”Carcinogenesis24(8): 1317-1323 (2003).
Davies et al., “The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo,”Int. J. Cancer106:348-354 (2003).
Christensen et al., “A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo,”Cancer Research63: 7345-7355 (2003).
Edwards et al., “Antineoplastic Activity and Cytotoxicity of Flavones, Isoflavones, and Flavanones”, Abstract XP-009035912, J. of Natural Products, pp. 85-91, 1979.
Database Chemabs, “Amino Acid Derivatives and Oximes of Flavones” Abstract XP-002295239, Chem. Of Heterocyclic Compounds, 2002.
Database Chemabs, “Benzo-.gamma.-pyrones. Part XIV. Reaction of C-substituted 2-phenyl-4H-1-benzopyran-4-ones with hydroxylamine”, Abstract XP-002295240, Polish J. of Chem., 1991.
Sen et al., “Search for New Antimalarials. Part V. Synthesis of Some 8-aminoalkylamino- and 8-dialkylaminoalkylamino-chromones”, Abstract XP-009035940, J. of the Indian Chem. Soc., Calcutta, pp. 217-222, 1960.
Weng, Lingling, et al., Database Chemabs, “Preparation of Isoflavone Alicyclic Ethers and Oxime Derivatives”, Abstact XP-002295241, Materia Medica Inst., Huaxi Med. College, Peop. Rep. China, 1993.
Beugelmans et al., “Action of Hydroxylamine on Chromone and Khellin. Oxime vs. Isoxazoles Structures”, XP-002295236, J. of Organic Chem., vol. 42, No. 8, pp. 1356-1360, 1977.
Database Chemab, “Thiazole Analogs of Isoflavones”, Abstact XP-002295242, Khimichni ta Biologichni Nauki, 1980.
Spatz et al., “7,2′,4′-Trimethoxyflavone”, J. of Organic Chem., Abstract XP-002295237, vol. 24, No. 9, pp. 1381-1382, 1959.
Eiden et al., “Uber die Reaktion Von Hydroxylamin Mit 2,6-Dimethyl-3-Acetylchromon”, Tetrahedron Letters, Abstract XP-002295238, vol. 17, pp. 1439-1442, 1970.

Affiliated with

Also associated with

Rating

Compositions useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of protein kinases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4141516